BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30627061)

  • 1. Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model.
    Bellaye PS; Oudot A; Vrigneaud JM; Raguin O; Bichat F; Vaslin A; Maby-El Hajjami H; Zanna C; Vuagniaux G; Fumoleau P; Denat F; Brunotte F; Collin B
    Contrast Media Mol Imaging; 2018; 2018():8494031. PubMed ID: 30627061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
    Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
    Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.
    Matzinger O; Viertl D; Tsoutsou P; Kadi L; Rigotti S; Zanna C; Wiedemann N; Vozenin MC; Vuagniaux G; Bourhis J
    Radiother Oncol; 2015 Sep; 116(3):495-503. PubMed ID: 26096848
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Liu H; Sun H; Zhang B; Liu S; Deng S; Weng Z; Zuo B; Yang J; He Y
    Breast Cancer; 2020 May; 27(3):372-380. PubMed ID: 31781983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer.
    Montemagno C; Bacot S; Ahmadi M; Kerfelec B; Baty D; Debiossat M; Soubies A; Perret P; Riou L; Fagret D; Broisat A; Ghezzi C
    J Nucl Med; 2018 Jul; 59(7):1056-1062. PubMed ID: 29572256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death.
    Thibault B; Genre L; Le Naour A; Broca C; Mery E; Vuagniaux G; Delord JP; Wiedemann N; Couderc B
    Sci Rep; 2018 Dec; 8(1):17862. PubMed ID: 30552344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of triple negative breast cancer response to cisplatin treatment using diffusion-weighted MRI and
    Nguyen-Thu H; Hanaoka H; Nakajima T; Yamaguchi A; Nguyen-Cong T; Kartamihardja AAP; Tsushima Y
    Breast Cancer; 2018 May; 25(3):334-342. PubMed ID: 29357023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.
    Vorobyeva A; Bezverkhniaia E; Konovalova E; Schulga A; Garousi J; Vorontsova O; Abouzayed A; Orlova A; Deyev S; Tolmachev V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066684
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ma G; Liu C; Lian W; Zhang Y; Yuan H; Zhang Y; Song S; Yang Z
    Ann Nucl Med; 2021 May; 35(5):600-607. PubMed ID: 33689138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells.
    Langdon CG; Wiedemann N; Held MA; Mamillapalli R; Iyidogan P; Theodosakis N; Platt JT; Levy F; Vuagniaux G; Wang S; Bosenberg MW; Stern DF
    Oncotarget; 2015 Nov; 6(35):37410-25. PubMed ID: 26485762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.
    Groheux D; Hindié E; Giacchetti S; Hamy AS; Berger F; Merlet P; de Roquancourt A; de Cremoux P; Marty M; Hatt M; Espié M
    Eur J Cancer; 2014 Jul; 50(11):1864-71. PubMed ID: 24841218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
    Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.
    Belhocine TZ; Blankenberg FG; Kartachova MS; Stitt LW; Vanderheyden JL; Hoebers FJ; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2083-97. PubMed ID: 26275392
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Song N; Zhao L; Zhu M; Zhao J
    Contrast Media Mol Imaging; 2019; 2019():9502712. PubMed ID: 31598115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations.
    Santos do Carmo F; Ricci-Junior E; Cerqueira-Coutinho C; Albernaz MS; Bernardes ES; Missailidis S; Santos-Oliveira R
    Int J Nanomedicine; 2017; 12():53-60. PubMed ID: 28053523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of radiation-induced tissue apoptosis by (99m)Tc(I)-his (6)-annexin A5.
    Lin KJ; Wu CC; Pan YH; Chen FH; Fu SY; Chiang CS; Hong JH; Lo JM
    Ann Nucl Med; 2012 Apr; 26(3):272-80. PubMed ID: 22278351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
    Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
    Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between MRI Features and Standardized Uptake Value of 18F-FDG PET/CT in Triple-Negative Breast Cancer.
    Choi BB; Lee JS; Kim KH
    Oncol Res Treat; 2018; 41(11):706-711. PubMed ID: 30321870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single photon emission computed tomography imaging of cerebral blood flow, blood-brain barrier disruption, and apoptosis time course after focal cerebral ischemia in rats.
    Garrigue P; Giacomino L; Bucci C; Muzio V; Filannino MA; Sabatier F; Dignat-George F; Pisano P; Guillet B
    Int J Stroke; 2016 Jan; 11(1):117-26. PubMed ID: 26763027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.
    Abdelhamed S; Yokoyama S; Refaat A; Ogura K; Yagita H; Awale S; Saiki I
    Anticancer Res; 2014 Apr; 34(4):1893-9. PubMed ID: 24692724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.